Rafael Carretero Selected Research

Interleukins

1/2009

A polymorphism in the interleukin-10 promoter affects the course of disease in patients with clear-cell renal carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rafael Carretero Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 08/2008
6	Neoplasm Metastasis (Metastasis) 03/2015 - 08/2008
4	Melanoma (Melanoma, Malignant) 01/2022 - 08/2008
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2013 - 01/2009
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Adenocarcinoma 03/2015
1	Breast Neoplasms (Breast Cancer) 08/2013
1	Urinary Bladder Neoplasms (Bladder Cancer) 08/2011
1	Inflammation (Inflammations) 03/2010
1	Kidney Neoplasms (Kidney Cancer) 03/2010
1	Lymphadenopathy 01/2009
1	Disease Progression 01/2009
1	Prostatic Neoplasms (Prostate Cancer) 12/2008

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 01/2022 - 11/2008
2	AntibodiesIBA 01/2022 - 03/2015
2	ChemokinesIBA 05/2009 - 12/2008
2	Histocompatibility Antigens Class IIBA 11/2008 - 08/2008
1	Cell Surface ReceptorsIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	GTP-Binding Proteins (G-Protein)IBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Carcinoembryonic AntigenIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Cell Adhesion MoleculesIBA 01/2022
1	Mucin-3IBA 01/2022
1	CEACAM1 ProteinIBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016
1	Chemotactic FactorsIBA 06/2015
1	Epidermal Growth Factor (EGF)IBA 03/2015
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 03/2015
1	ProteomeIBA 08/2013
1	Oxidoreductases (Dehydrogenase)IBA 08/2013
1	Proteins (Proteins, Gene)FDA Link 08/2013
1	Sulfhydryl Compounds (Thiols)IBA 08/2013
1	boron oxide (BO2)IBA 08/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	InterferonsIBA 07/2012
1	HLA-DR Antigens (HLA-DR)IBA 07/2012
1	HLA-A Antigens (HLA-A)IBA 07/2012
1	HLA Antigens (Human Leukocyte Antigens)IBA 08/2011
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 08/2011
1	Interleukin-18 (Interleukin 18)IBA 03/2010
1	InterleukinsIBA 01/2009
1	Interleukin-10 (Interleukin 10)IBA 01/2009
1	Chemokine CCL5IBA 12/2008
1	Immunologic Factors (Immunomodulators)IBA 11/2008
1	Cancer VaccinesIBA 11/2008

Therapy/Procedure

6	Immunotherapy 01/2022 - 08/2008
2	Therapeutics 03/2015 - 11/2008
1	Radiotherapy 03/2015